n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial - Hedengran, Anne; Szecsi, Pal B.; Dyerberg, Jørn; Harris, William S.; Stender, Steen (Lipids, 2015)
Keywords: Aged; Biomedical and Life Sciences; Cardiovascular diseases; Cholesterol; Docosahexaenoic acids; Double-Blind Method; Eicosapentaenoic acid; erythrocytes; esterification; Esters; Esters - chemistry; Esters - therapeutic use; fasting; Fasting - blood; Fatty Acids, Omega-3 - chemistry; Fatty Acids, Omega-3 - therapeutic use; Female; Glycerides - chemistry; Glycerides - therapeutic use; glycerol; Health risks; Heart rate; high density lipoprotein; Humans; hypertriglyceridemia; Hypertriglyceridemia - blood; Hypertriglyceridemia - diet therapy; Life Sciences; Lipidology; Lipoprotein‐associated phospholipase A2; Male; Medical Biochemistry; Medicinal Chemistry; Microbial Genetics and Genomics; Middle Aged; Neurochemistry; Non‐fasting; Nutrition; n‐3 Polyunsaturated fatty acid; omega-3 fatty acids; Omega‐3 acylglycerol; Omega‐3 ethyl ester; Original Article; phospholipase A2; Polyunsaturated fatty acids; risk; Triacylglycerols; Triglycerides - blood; Omega-3 acylglycerol; Heart rate; n-3 Polyunsaturated fatty acid; Lipoprotein-associated phospholipase A2; Omega-3 ethyl ester; Docosahexaenoic acids; Non-fasting; Eicosapentaenoic acid; Triacylglycerols